NMD Pharma A/S — Credit Rating and Financial Key Figures
CVR number: 36899069
Palle Juul-Jensens Boulevard 82, 8200 Aarhus N
Income statement (kEUR)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -7 870.12 | -11 029.05 | -9 480.44 | -18 817.94 | -27 874.34 |
Employee benefit expenses | -2 743.00 | -3 223.88 | -3 499.79 | -4 403.80 | -5 942.97 |
Total depreciation | -18.92 | -35.91 | |||
EBIT | -10 613.13 | -14 252.93 | -12 980.23 | -23 240.65 | -33 853.22 |
Other financial income | 107.50 | 921.18 | |||
Other financial expenses | -51.46 | -97.72 | -80.32 | -4.84 | -58.22 |
Pre-tax profit | -10 664.59 | -14 350.64 | -13 060.55 | -23 138.00 | -32 990.26 |
Income taxes | 736.56 | 736.56 | 736.56 | 736.56 | 736.56 |
Net earnings | -9 928.03 | -13 614.08 | -12 323.99 | -22 401.44 | -32 253.70 |
Assets (kEUR)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 94.61 | 160.60 | 124.70 | ||
Tangible assets total | 94.61 | 160.60 | 124.70 | ||
Holdings in group member companies | 0.00 | 0.00 | 0.00 | ||
Investments total | 0.00 | 0.00 | 0.00 | ||
Non-current other receivables | 76.97 | 80.91 | 82.61 | 121.29 | 129.99 |
Long term receivables total | 76.97 | 80.91 | 82.61 | 121.29 | 129.99 |
Inventories total | |||||
Current amounts owed by group member comp. | 67.94 | ||||
Prepayments and accrued income | 16.93 | 36.16 | 100.99 | ||
Current other receivables | 1 226.03 | 286.45 | 319.04 | 277.58 | 220.35 |
Current deferred tax assets | 736.56 | 736.56 | 736.56 | 736.56 | 736.56 |
Short term receivables total | 1 962.59 | 1 023.01 | 1 140.48 | 1 050.31 | 1 057.90 |
Cash and bank deposits | 9 448.99 | 3 815.83 | 25 820.86 | 45 060.42 | 38 081.11 |
Cash and cash equivalents | 9 448.99 | 3 815.83 | 25 820.86 | 45 060.42 | 38 081.11 |
Balance sheet total (assets) | 11 488.55 | 4 919.75 | 27 138.56 | 46 392.63 | 39 393.69 |
Equity and liabilities (kEUR)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 192.93 | 226.46 | 394.10 | 576.55 | 690.59 |
Retained earnings | 18 978.22 | 15 983.20 | 37 062.85 | 64 497.75 | 66 957.70 |
Profit of the financial year | -9 928.03 | -13 614.08 | -12 323.99 | -22 401.44 | -32 253.70 |
Shareholders equity total | 9 243.12 | 2 595.58 | 25 132.97 | 42 672.87 | 35 394.59 |
Non-current other liabilities | 201.31 | 201.31 | |||
Non-current liabilities total | 201.31 | 201.31 | |||
Current loans from credit institutions | 12.16 | 14.59 | 31.81 | 18.14 | 10.91 |
Current trade creditors | 1 446.57 | 1 669.17 | 1 526.02 | 3 016.39 | 2 943.02 |
Current owed to group member | 76.80 | 158.58 | |||
Other non-interest bearing current liabilities | 585.39 | 439.10 | 447.77 | 608.42 | 886.59 |
Current liabilities total | 2 044.12 | 2 122.85 | 2 005.60 | 3 719.75 | 3 999.10 |
Balance sheet total (liabilities) | 11 488.55 | 4 919.75 | 27 138.56 | 46 392.63 | 39 393.69 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.